April 30, 2024
2 minutes
Invest-NL accelerates healthcare innovation with investment in Vitestro
Today, Invest-NL announced its investment in Vitestro, a leading Dutch startup specializing in the development of autonomous blood-drawing devices. This € 5 million investment is part of a Series A1 funding round totaling € 20 million. Vitestro aims to accelerate the commercialization of the technology, including expansion into the US.
In a world where healthcare faces increasing challenges, such as staff shortages and a rising demand for medical services, Vitestro's technology offers a significant solution. Their autonomously operating, image-guided blood-drawing device helps reduce staff shortages in hospitals and clinics by automating the blood-drawing proces. The device can safely and accurately draw blood from patients.
The investment in Vitestro is an investment in the future of healthcare. By automating routine processes, medical professionals can focus on more complex and personalized patient care.
Vitestro's innovation is made possible by a combination of artificial intelligence, advanced ultrasound, and robotics. This solution contributes to more efficient healthcare and higher patient satisfaction.
Investing in solving staff shortages
"Our investment in Vitestro reflects our confidence in their innovative technology and its potential for societal impact. Through this investment, we are supporting an innovative company that is not only commercially viable but also directly contributes to solving staff shortages in healthcare," emphasizes Koen van Breugel, investment manager at Invest-NL, the importance of this investment.
The funding round is led by Sonder Capital, with new investors such as NYBC Ventures and the European Innovation Council Fund (EIC Fund), along with existing private investors, also participating.
Questions about this investment? Koen is happy to help!
Koen van Breugel
sr. investment manager
